首页> 外国专利> Cosmetic or dermatological preparations containing oligo-peptides to lighten the skin of age spots, or to prevent skin tanning, in particular skin tanning caused by UV radiation

Cosmetic or dermatological preparations containing oligo-peptides to lighten the skin of age spots, or to prevent skin tanning, in particular skin tanning caused by UV radiation

机译:含有寡肽的化妆品或皮肤病学制剂,可减轻老年斑的皮肤,或防止皮肤晒黑,尤其是紫外线辐射引起的皮肤晒黑

摘要

Cosmetic or pharmaceutical compositions comprise one or more monomeric- or homo- or hetero- dimeric-, trimeric- or tetrameric- oligopeptides where the oligopeptides are based upon the sequence Val-Val-Arg-Pro. Cosmetic or pharmaceutical compositions comprise one or more monomeric- or homo- or hetero- dimeric-, trimeric- or tetrameric- oligopeptides where the oligopeptides: (a) are based upon monomers of formula (I) in which a Val may be replaced by Gly, Leu, Ile, Ser, Thr, Met or especially Ala; or (b) are based upon monomers of formula H2N-R-Val-Val-Arg-Pro-R'-COOH (II); or (c) have a molecular weight of 0.5-100 kDa and are based upon single or repeated units of (I) or (II); or (d) are acylated at the N-terminal and are of formula R1-C(=O)-NH-R-Val-Val-Arg-Pro-R'-COOH (III); or (e) are amidated at the C-terminus and are of formula H2N-R-Val-Val-Arg-Pro-R'-C(=O)N(R2)2 (IV); (f) are amidated at the C-terminus and acylated at the N-terminus and are of formula R-C(=O)-NH-R-Val-Val-Arg-Pro-R'-C(=O)-N(R2)2 (V); or (g) are of formula (II)-(V), containing 1-25 Val-Val-Arg-Pro units and where R = a bond or an amino acid sequence with up to 5 amino acid units and R' = an amino acid sequence of up to 15 amino acid units. R, R' = amino acid sequences of 0-5 amino acid units; R1 = hydrocarbon group (especially 1-30C alkyl); R2 = H or R1. An Independent claim is included for use of the above oligopeptides for treatment of unwanted skin-pigmentation.
机译:化妆品或药物组合物包含一种或多种单体-或同-或异-二聚-,三聚或四聚-寡肽,其中所述寡肽基于序列Val-Val-Arg-Pro。化妆品或药物组合物包含一种或多种单体或同二聚或异二聚,三聚或四聚寡肽,其中寡肽:(a)基于式(I)的单体,其中Val可以被Gly取代,Leu,Ile,Ser,Thr,Met或尤其是Ala; (b)基于式H2N-R-Val-Val-Arg-Pro-R'-COOH(II)的单体; (c)分子量为0.5-100 kDa,并且基于(I)或(II)的单个或重复单元;或或(d)在N-末端被酰化并且具有式R1-C(= O)-NH-R-Val-Val-Arg-Pro-R'-COOH(III);或(e)在C端酰胺化并且具有式H 2 N-R-Val-Val-Arg-Pro-R′-C(= O)N(R 2)2(IV); (f)在C端酰胺化并在N端酰化,并且具有式RC(= O)-NH-R-Val-Val-Arg-Pro-R'-C(= O)-N( R2)2(V);或(g)具有式(II)-(V),包含1-25个Val-Val-Arg-Pro单元,并且其中R =键或具有最多5个氨基酸单元的氨基酸序列,R'=氨基酸序列最多15个氨基酸单位。 R,R′= 0-5个氨基酸单元的氨基酸序列; R1 =烃基(特别是1-30C烷基); R2 = H或R1。对于上述寡肽用于治疗不需要的皮肤色素沉着的用途,包括独立权利要求。

著录项

  • 公开/公告号DE59909730D1

    专利类型

  • 公开/公告日2004-07-22

    原文格式PDF

  • 申请/专利权人 BEIERSDORF AG;

    申请/专利号DE19995009730T

  • 发明设计人 SCHOENROCK DR.;MAX DR.;HEARING DR.;

    申请日1999-07-23

  • 分类号C07K5/10;C07K7/06;A61K7/42;

  • 国家 DE

  • 入库时间 2022-08-21 22:41:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号